Welcome to Avastin.net
Avastin.net is an online resource for medical professionals
This website provides background information on the role of angiogenesis in the development of solid tumours, as well as insights into the action, efficacy and tolerability of Avastin across a number of different tumour types.
Highlights ECCO/ESMO 2009
Highlights from the official F. Hoffmann-La Roche satellite symposium at the joint ECCO 15–34th ESMO Multidisciplinary Congress.
Watch Professor Camillo Porta present the latest clinical trial data on the efficacy of first-line Avastin plus interferon in metastatic RCC.
Watch Professor Frank Griesinger present the latest clinical trial data on the efficacy of first-line Avastin-based therapy in advanced NSCLC.
Download a slide
set on the search
for clinically useful
biomarkers for
angiogenesis
Watch Dr Fairooz Kabbinavar as he presented “Controlling angiogenesis to control tumour growth” at the Anti-angiogenesis Clinical Experience Exchange Meeting held in Madrid, Spain in April 2009.
Click here for a listing of upcoming oncology congresses.
- Disclaimer: Avastin.net is a comprehensive resource for healthcare professionals outside the US. If you are a US resident please visit www.avastin.comThe information on this site is not country-specific and may contain information that is outside the approved indications in the country in which you are located.
- © 2010 F. Hoffmann-La Roche Ltd.